News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States
Novamind Inc.
Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan
Tryp Therapeutics
George Mashour, M.D., Ph.D | Tryp Therapeutics
Tryp Therapeutics
Braxia Scientific Secures Approval for Direct Billing Insurance on Ketamine Treatments for Veterans Affairs Canada Clients
Braxia Scientific Corp.
Filament Health to Host Virtual Investor Event
Filament Health
Dr. Jennifer Miller | Principal Investigator, Tryp Therapeutics
Tryp Therapeutics
Core One Labs Announces Details of Consolidation to Meet Nasdaq Listing Requirements
Core One Labs Inc.
Ian Burnstein Joins Wesana Health Board of Directors
Wesana Health
Red Light Holland Expected Merger Partner Creso Pharma Completes Acquisition of Halucenex Life Sciences Inc
Red Light Holland
Creso Pharma
Tryp Therapeutics to Host Q3 Investor Day on July 29, 2021
Tryp Therapeutics
Nova Mentis Appoints Dr. Stephen Glazer as Director and Chief Science Officer
Nova Mentis Life Science
Ian Burnstein Joins Wesana Health Advisory Board
Wesana Health
PharmaDrug Reports Positive Preclinical Study Results of Cepharanthine to Treat Cancers
Pharmadrug Inc.
Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The Transactions
Wesana Health
PsyBio Therapeutics Announces Uplisting to OTCQB Venture Market
PsyBio Therapeutics
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.